Paxman Q4 (Initial take): Sales did not live up to our expectations - Redeye

Redeye provides an initial take following Paxman’s Q4 2025 report. The report did not live up to our expectations, with sales coming in 7% below our estimate. We will publish a research update with a more detailed review of the report. We expect to revise our sales estimates downwards, which will most likely result in a lower valuation of the company.

Länk till analysen i sin helhet: https://www.redeye.se/research/1154951/paxman-q4-initial-take-sales-did-not-live-up-to-our-expectations?utm_source=finwire&utm_medium=RSS